Pharmala Biotech Holdings Inc.
CSE:MDMA View the CSE listing
1 video on CSE TV
MDMA's Real-World ImpactSoRI 2025 Issuer Update (CSE:MDMA)
2 stories on the blog
2025 Year-End RewindJanuary Highlights As 2025 comes to an end, we’re sharing our favourite highlights from another incredible year at the CSE. In January, we hit the ground running with a strong presence at VRIC, hosted our signature Mining Over Canada Reception, joined global financial market leaders on the slopes of the Italian Alps, and released our…
PharmAla Biotech Holdings Inc. (CSE:MDMA) Joins the CSE for a Virtual Market OpenThe CSE warmly welcomed PharmAla Biotech Holdings Inc. (CSE:MDMA) for a virtual Market Open on January 26, 2022. PharmAla is focused on the manufacturing of active pharmaceutical ingredients of the substituted methylenedioxy- phenethylamines class (MDXX), including 3,4-methylenedioxymethamphetamine (MDMA). PharmAla also intends to develop novel formulations of MDMA and MDXX, as well as novel drug delivery…